RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more
Market Cap & Net Worth: RaySearch Laboratories AB (publ) (RSLBF)
RaySearch Laboratories AB (publ) (PINK:RSLBF) has a market capitalization of $692.99 Million ($692.99 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #9149 globally and #4462 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RaySearch Laboratories AB (publ)'s stock price $22.50 by its total outstanding shares 30799536 (30.80 Million).
RaySearch Laboratories AB (publ) Market Cap History: 2015 to 2025
RaySearch Laboratories AB (publ)'s market capitalization history from 2015 to 2025. Data shows growth from $404.63 Million to $692.99 Million (0.00% CAGR).
RaySearch Laboratories AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RaySearch Laboratories AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.47x
RaySearch Laboratories AB (publ)'s market cap is 0.47 times its annual revenue
1.54x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.77x
RaySearch Laboratories AB (publ)'s market cap is 2.77 times its annual earnings
252.98x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $404.63 Million | $397.60 Million | $70.21 Million | 1.02x | 5.76x |
| 2016 | $591.26 Million | $531.47 Million | $151.41 Million | 1.11x | 3.91x |
| 2017 | $606.66 Million | $585.09 Million | $117.63 Million | 1.04x | 5.16x |
| 2018 | $373.23 Million | $627.22 Million | $78.52 Million | 0.60x | 4.75x |
| 2019 | $343.67 Million | $741.58 Million | $50.41 Million | 0.46x | 6.82x |
| 2020 | $307.95 Million | $651.61 Million | -$9.08 Million | 0.47x | N/A |
| 2021 | $202.32 Million | $641.67 Million | -$47.31 Million | 0.32x | N/A |
| 2022 | $169.37 Million | $843.65 Million | $23.78 Million | 0.20x | 7.12x |
| 2023 | $286.39 Million | $1.02 Billion | $81.57 Million | 0.28x | 3.51x |
| 2024 | $564.56 Million | $1.19 Billion | $203.51 Million | 0.47x | 2.77x |
Competitor Companies of RSLBF by Market Capitalization
Companies near RaySearch Laboratories AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to RaySearch Laboratories AB (publ) by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
RaySearch Laboratories AB (publ) Historical Marketcap From 2015 to 2025
Between 2015 and today, RaySearch Laboratories AB (publ)'s market cap moved from $404.63 Million to $ 692.99 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $692.99 Million | +22.75% |
| 2024 | $564.56 Million | +97.13% |
| 2023 | $286.39 Million | +69.09% |
| 2022 | $169.37 Million | -16.29% |
| 2021 | $202.32 Million | -34.30% |
| 2020 | $307.95 Million | -10.39% |
| 2019 | $343.67 Million | -7.92% |
| 2018 | $373.23 Million | -38.48% |
| 2017 | $606.66 Million | +2.60% |
| 2016 | $591.26 Million | +46.12% |
| 2015 | $404.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of RaySearch Laboratories AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $692.99 Million USD |
| MoneyControl | $692.99 Million USD |
| MarketWatch | $692.99 Million USD |
| marketcap.company | $692.99 Million USD |
| Reuters | $692.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.